Sebi panel moots leeway for FIIs in derivatives
Some members of the technical group on the new derivatives products of the SEBI on Thursday expressed the view that the growth of the derivatives segment was hindered by some regulatory issues pertaining to institutional investors and that they must be relaxed to boost volumes in the segment.



Profits over people make Glaxo `enemy of the future'
It’s for choosing profits over people that makes British American Tobacco (BAT), Glaxo Wellcome and Ford/Firestone among the world's ten worst corporations, according to Multinational Monitor magazine.



Sugar reforms to lift mill revenue, exports
India's moves to deregulate the sugar sector will raise mill revenues and bring down domestic prices, making exports viable, analysts and traders said on Thursday.



Other headlines
India to get more time for meeting WTO standards
US allows sale of faster computers to India
MNCs keen on picking stake in Paradip refinery
Infosys to expand Hyderabad software unit
Telco hikes Indica prices
IGNCA adopts IT mantra to keep afloat